Hepatic Infarction Caused by Portal Vein Thrombophlebitis Misdiagnosed as Infiltrative Hepatic Malignancy with Neoplastic Thrombus.
暂无分享,去创建一个
Y. Lee | S. Hwang | K. Rim | Eunju Kim | Hana Park | K. Park | N. Cho | Minjung Shim | T. Yang | J. H. Lee | A. Woo
[1] P. Schirmacher,et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] S. Olliff,et al. Portal vein thrombosis in cirrhosis: Controversies and latest developments. , 2015, World journal of gastroenterology.
[3] Y. Chawla,et al. Portal vein thrombosis. , 2015, Journal of clinical and experimental hepatology.
[4] H. Schlitt,et al. Clinical Management of Acute Portal/Mesenteric Vein Thrombosis , 2014, Visceral Medicine.
[5] Jiani Hu,et al. Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging , 2014, BMC Cancer.
[6] S. Mahadeva,et al. Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding. , 2014, World journal of gastroenterology.
[7] D. Weisman,et al. Pylephlebitis: a rare complication of an intra-abdominal infection , 2013, Journal of community hospital internal medicine perspectives.
[8] A. Singhal,et al. Elevation of CA 125 and CA 19–9 in patients with end-stage liver disease , 2012, The International journal of biological markers.
[9] J. Koskinas,et al. Pylephlebitis: An overview of non-cirrhotic cases and factors related to outcome , 2010, Scandinavian journal of infectious diseases.
[10] G. Sotiropoulos,et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] L. Schwartz,et al. Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population , 2010, Abdominal Imaging.
[12] A. Gasbarrini,et al. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. , 2010, World journal of gastroenterology.
[13] D. Valla,et al. Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow‐up study , 2010, Hepatology.
[14] V. Shah. Molecular mechanisms of increased intrahepatic resistance in portal hypertension. , 2007, Journal of clinical gastroenterology.
[15] M. Mori,et al. Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Clinical Characteristics, Prognosis, and Patient Survival Analysis , 2007, Digestive Diseases and Sciences.
[16] S. Pavai,et al. The clinical significance of elevated levels of serum CA 19-9. , 2003, The Medical journal of Malaysia.
[17] D. Valla. Vascular disorders of the liver. , 2003, Acta gastro-enterologica Belgica.
[18] M. Tublin,et al. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. , 1997, AJR. American journal of roentgenology.
[19] W. Steinberg,et al. Elevated serum levels of tumor marker CA19-9 in acute cholangitis , 1988, Digestive Diseases and Sciences.
[20] H. Dale,et al. The control of circulation through the liver , 1932, The Journal of physiology.
[21] Seong Jin Park,et al. Portal vein thrombosis: CT features , 2007, Abdominal Imaging.